Year |
Citation |
Score |
2019 |
Han Z, Liu G, Wang R, Dong XQ, Zhang X. Highly efficient Ir-catalyzed asymmetric hydrogenation of benzoxazinones and derivatives with a Brønsted acid cocatalyst. Chemical Science. 10: 4328-4333. PMID 31057759 DOI: 10.1039/C8Sc05797D |
0.311 |
|
2018 |
Francesco MED, Marszalek JR, McAfoos T, Carroll CL, Kang Z, Liu G, Theroff JP, Bardenhager JP, Bandi ML, Molina JR, Gera S, Protopopova M, Sun Y, Do MKG, Feng N, et al. Abstract 1655: Discovery and development of IACS-010759, a novel inhibitor of Complex I currently in phase I studies to exploit oxidative phosphorylation dependency in acute myeloid leukemia and solid tumors Cancer Research. 78: 1655-1655. DOI: 10.1158/1538-7445.Am2018-1655 |
0.302 |
|
2017 |
Jones P, Francesco MED, Molina JM, Protopopova M, Bandi M, Bardenhagen J, Bristow CA, Carroll CL, Feng N, Do MKG, Greer JM, Konopleva M, Kang Z, Liu G, McAfoos T, et al. Abstract PR01: IACS-010759 a novel inhibitor of oxidative phosphorylation advancing into first-in-human studies to exploit metabolic vulnerabilities Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Pmccavuln16-Pr01 |
0.317 |
|
2017 |
Molina J, Bandi M, Bardenhagen J, Bristow C, Carroll C, Chang E, Cross J, Daver N, Feng N, Do MG, Greer J, Han J, Hirst J, Huang S, Jiang Y, ... ... Liu G, et al. Abstract 4971: IACS-010759, a novel inhibitor of complex I in Phase I clinical development to target OXPHOS dependent tumors Cancer Research. 77: 4971-4971. DOI: 10.1158/1538-7445.Am2017-4971 |
0.305 |
|
2016 |
Protopopova M, Bandi M, Sun Y, Bardenhagen J, Bristow C, Carroll C, Chang E, Feng N, Do MG, Greer J, Konopleva M, Matre P, Kang Z, Liu G, Muller F, et al. Abstract A65: IACS-10759: A novel OXPHOS inhibitor that selectively kills tumors with metabolic vulnerabilities Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Metca15-A65 |
0.301 |
|
2016 |
Molina JR, Protopopova M, Bandi M, Bardenhagen J, Bristow C, Carroll C, Chang E, Feng N, Do MG, Greer J, Huang S, Jiang Y, Konopleva M, Matre P, Han J, ... ... Liu G, et al. Abstract 335: Title: IACS-010759 is a novel clinical candidate that targets AML cells by inducing a metabolic catastrophe through inhibition of oxidative phosphorylation Cancer Research. 76: 335-335. DOI: 10.1158/1538-7445.Am2016-335 |
0.313 |
|
2015 |
Protopopova M, Bandi M, Bardenhagen J, Bristow C, Carroll C, Chang E, Feng N, Do MG, Greer J, Konopleva M, Matre P, Kang Z, Liu G, Muller F, Lofton T, et al. Abstract 4380: IACS-10759: A novel OXPHOS inhibitor which selectively kill tumors with metabolic vulnerabilities Cancer Research. 75: 4380-4380. DOI: 10.1158/1538-7445.Am2015-4380 |
0.308 |
|
2015 |
Molina JR, Protopopova M, Bandi M, Bardenhagen J, Bristow C, Alimova M, Carroll C, Chang E, Feng N, Do MG, Greer J, Huang S, Jiang Y, Konopleva M, Matre P, ... ... Liu G, et al. Abstract LB-A15: IACS-010759 is a novel inhibitor of oxidative phosphorylation that selectively targets AML cells by inducing a metabolic catastrophe Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-Lb-A15 |
0.306 |
|
2015 |
Wang Y, Liu G, Reyes JCP, Duverna R. One-Pot Synthesis of 3-Cyano-2-pyridones Journal of Heterocyclic Chemistry. 52: 1185-1191. DOI: 10.1002/Jhet.2227 |
0.615 |
|
2014 |
Marszalek JR, Bandi M, Bardenhagen J, Bristow C, Carroll C, Chang E, Feng N, Czako B, Do MG, Greer J, Johnson RM, Konopleva M, Kang Z, Liu G, Lofton T, et al. Abstract 949: Identification of OXPHOS inhibitors which selectively kill tumors with specific metabolic vulnerabilities Cancer Research. 74: 949-949. DOI: 10.1158/1538-7445.Am2014-949 |
0.314 |
|
2013 |
Liu G, Shirley ME, Van KN, McFarlin RL, Romo D. Rapid assembly of complex cyclopentanes employing chiral, α,β-unsaturated acylammonium intermediates. Nature Chemistry. 5: 1049-57. PMID 24256870 DOI: 10.1038/Nchem.1788 |
0.528 |
|
2012 |
Liu G, Shirley ME, Romo D. A diastereoselective, nucleophile-promoted aldol-lactonization of ketoacids leading to bicyclic-β-lactones. The Journal of Organic Chemistry. 77: 2496-500. PMID 22260519 DOI: 10.1021/Jo202252Y |
0.524 |
|
2011 |
Liu G, Romo D. Total synthesis of (+)-omphadiol. Angewandte Chemie (International Ed. in English). 50: 7537-40. PMID 21761524 DOI: 10.1002/Anie.201102289 |
0.564 |
|
2011 |
Liu G, Romo D. Cover Picture: Total Synthesis of (+)-Omphadiol (Angew. Chem. Int. Ed. 33/2011) Angewandte Chemie International Edition. 50: 7449-7449. DOI: 10.1002/Anie.201104527 |
0.545 |
|
2011 |
Liu G, Romo D. Titelbild: Total Synthesis of (+)-Omphadiol (Angew. Chem. 33/2011) Angewandte Chemie. 123: 7587-7587. DOI: 10.1002/Ange.201104527 |
0.565 |
|
2009 |
Liu G, Romo D. Enantioselective synthesis of schulzeines B and C via a beta-lactone-derived surrogate for bishomoserine aldehyde. Organic Letters. 11: 1143-6. PMID 19209875 DOI: 10.1021/Ol802992M |
0.545 |
|
2007 |
Rzasa RM, Kaller MR, Liu G, Magal E, Nguyen TT, Osslund TD, Powers D, Santora VJ, Viswanadhan VN, Wang HL, Xiong X, Zhong W, Norman MH. Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors. Bioorganic & Medicinal Chemistry. 15: 6574-95. PMID 17697781 DOI: 10.1016/j.bmc.2007.07.005 |
0.614 |
|
Show low-probability matches. |